Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADI Analog Devices	$244.68 -0.2%	$225.10	$158.65 ▼ $253.18	$121.42B	1.02	3.60 million shs	2.04 million shs
GM General Motors	$53.36 +0.4%	$49.17	$38.96 ▼ $61.24	$51.30B	1.32	12.71 million shs	7.70 million shs
LEN Lennar	$114.04 -2.1%	$109.27	$98.42 ▼ $187.61	$30.08B	1.33	2.74 million shs	2.64 million shs
MSGE Madison Square Garden Entertainment	$39.50 +0.9%	$37.70	$28.29 ▼ $44.14	$1.60B	0.45	356,610 shs	240,544 shs
OXY Occidental Petroleum	$46.33 +1.0%	$42.94	$34.79 ▼ $64.76	$45.59B	0.84	11.86 million shs	7.60 million shs
PFE Pfizer	$25.65 -0.5%	$23.86	$20.92 ▼ $31.54	$145.83B	0.58	41.82 million shs	34.84 million shs
TRIL Trillium Therapeutics	$18.44	$18.12	$5.80 ▼ $20.96	$1.94B	2.08	1.87 million shs	8 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADI Analog Devices	+0.99%	-0.39%	+5.05%	+36.82%	+2.85%
GM General Motors	+0.97%	+0.35%	+8.54%	+21.62%	+14.10%
LEN Lennar	+0.62%	+5.56%	+2.60%	+10.75%	-20.05%
MSGE Madison Square Garden Entertainment	+2.54%	+2.97%	+3.60%	+28.58%	+12.39%
OXY Occidental Petroleum	+0.65%	+4.55%	+4.49%	+21.72%	-25.33%
PFE Pfizer	+0.81%	+1.27%	+6.06%	+17.72%	-9.11%
TRIL Trillium Therapeutics	0.00%	0.00%	0.00%	0.00%	0.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ADI Analog Devices	4.661 of 5 stars	2.4	3.0	3.3	3.4	2.9	2.5	1.9
GM General Motors	4.2597 of 5 stars	2.1	4.0	2.5	0.0	3.3	1.7	2.5
LEN Lennar	4.8398 of 5 stars	3.1	3.0	2.5	2.3	3.1	1.7	3.1
MSGE Madison Square Garden Entertainment	2.547 of 5 stars	1.5	4.0	0.0	0.0	0.6	2.5	3.1
OXY Occidental Petroleum	4.7234 of 5 stars	3.1	4.0	3.3	0.0	3.4	1.7	2.5
PFE Pfizer	4.9782 of 5 stars	3.2	3.0	4.2	4.5	3.3	1.7	3.1
TRIL Trillium Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADI Analog Devices	2.77	Moderate Buy	$257.67	5.31% Upside
GM General Motors	2.27	Hold	$53.35	-0.01% Downside
LEN Lennar	2.24	Hold	$128.85	12.98% Upside
MSGE Madison Square Garden Entertainment	3.00	Buy	$42.75	8.23% Upside
OXY Occidental Petroleum	2.14	Hold	$53.62	15.73% Upside
PFE Pfizer	2.45	Hold	$28.55	11.31% Upside
TRIL Trillium Therapeutics	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest GM, LEN, OXY, PFE, ADI, MSGE, and TRIL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/11/2025	OXY Occidental Petroleum	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Perform ➝ Sector Perform	$40.00 ➝ $45.00
7/10/2025	ADI Analog Devices	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$285.00
7/8/2025	ADI Analog Devices	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$285.00 ➝ $300.00
7/7/2025	ADI Analog Devices	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$260.00 ➝ $290.00
7/7/2025	ADI Analog Devices	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$285.00 ➝ $280.00
7/7/2025	GM General Motors	CLSA Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Moderate Buy
6/26/2025	OXY Occidental Petroleum	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$42.00 ➝ $47.00
6/20/2025	LEN Lennar	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Perform ➝ Market Perform	$128.00 ➝ $114.00
6/20/2025	LEN Lennar	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Outperform ➝ Market Outperform	$150.00 ➝ $130.00
6/18/2025	ADI Analog Devices	Noble Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Outperform
6/18/2025	ADI Analog Devices	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Moderate Buy ➝ Strong-Buy

(Data available from 7/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADI Analog Devices	$9.43B	12.88	$10.74 per share	22.79	$70.88 per share	3.45
GM General Motors	$187.44B	0.27	$23.61 per share	2.26	$65.92 per share	0.81
LEN Lennar	$35.44B	0.85	$14.47 per share	7.88	$86.17 per share	1.32
MSGE Madison Square Garden Entertainment	$959.27M	1.67	$5.51 per share	7.17	($0.56) per share	-70.53
OXY Occidental Petroleum	$27.55B	1.65	$12.16 per share	3.81	$27.91 per share	1.66
PFE Pfizer	$62.46B	2.33	$4.38 per share	5.86	$15.62 per share	1.64
TRIL Trillium Therapeutics	$150K	12,907.39	N/A	N/A	$2.56 per share	7.20

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADI Analog Devices	$1.64B	$3.67	66.67	28.48	2.24	18.65%	9.56%	6.99%	8/20/2025 (Estimated)
GM General Motors	$6.01B	$6.94	7.69	4.51	1.41	3.08%	14.30%	3.51%	7/22/2025 (Estimated)
LEN Lennar	$3.93B	$12.09	9.43	7.33	4.89	9.20%	12.73%	8.57%	9/18/2025 (Estimated)
MSGE Madison Square Garden Entertainment	$144.30M	$2.74	14.42	22.19	N/A	13.49%	-1,070.57%	8.58%	8/15/2025 (Estimated)
OXY Occidental Petroleum	$3.06B	$2.46	18.83	12.03	N/A	11.20%	16.60%	5.18%	8/6/2025 (Estimated)
PFE Pfizer	$8.03B	$1.38	18.59	8.47	0.93	12.62%	20.33%	8.53%	8/5/2025 (Estimated)
TRIL Trillium Therapeutics	-$59.35M	$0.62	29.74	N/A	N/A	N/A	-23.31%	-18.66%	N/A

Latest GM, LEN, OXY, PFE, ADI, MSGE, and TRIL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2025	Q2 2025	OXY Occidental Petroleum	$0.38	N/A	N/A	N/A	$6.29 billion	N/A
8/5/2025	Q2 2025	PFE Pfizer	$0.57	N/A	N/A	N/A	$13.43 billion	N/A
7/22/2025	Q2 2025	GM General Motors	$2.52	N/A	N/A	N/A	$45.87 billion	N/A
6/16/2025	Q2 2025	LEN Lennar	$1.94	$1.90	-$0.04	$1.81	$8.21 billion	$8.38 billion
5/22/2025	Q2 2025	ADI Analog Devices	$1.70	$1.85	+$0.15	$1.14	$2.50 billion	$2.64 billion
5/7/2025	Q1 2025	OXY Occidental Petroleum	$0.74	$0.87	+$0.13	$0.77	$6.97 billion	$6.80 billion
4/29/2025	Q1 2025	GM General Motors	$2.63	$2.78	+$0.15	$3.35	$42.64 billion	$44.02 billion
4/29/2025	Q1 2025	PFE Pfizer	$0.67	$0.92	+$0.25	$0.52	$14.43 billion	$13.72 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADI Analog Devices	$3.96	1.62%	N/A	107.90%	23 Years
GM General Motors	$0.60	1.12%	N/A	8.65%	3 Years
LEN Lennar	$2.00	1.75%	N/A	16.54%	1 Years
MSGE Madison Square Garden Entertainment	N/A	N/A	N/A	N/A	N/A
OXY Occidental Petroleum	$0.96	2.07%	N/A	39.02%	5 Years
PFE Pfizer	$1.72	6.71%	N/A	124.64%	16 Years
TRIL Trillium Therapeutics	N/A	N/A	N/A	N/A	N/A

Latest GM, LEN, OXY, PFE, ADI, MSGE, and TRIL Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/25/2025	PFE Pfizer	quarterly	$0.43	7.08%	7/25/2025	7/25/2025	9/2/2025
6/20/2025	LEN Lennar	quarterly	$0.50	1.9%	7/3/2025	7/3/2025	7/18/2025
5/1/2025	OXY Occidental Petroleum	quarterly	$0.24	2.4%	6/10/2025	6/10/2025	7/15/2025
4/29/2025	GM General Motors	quarterly	$0.15	1.27%	6/6/2025	6/6/2025	6/19/2025
5/21/2025	ADI Analog Devices	quarterly	$0.99	1.78%	6/4/2025	6/4/2025	6/18/2025
4/23/2025	PFE Pfizer	quarterly	$0.43	7.69%	5/9/2025	5/9/2025	6/13/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ADI Analog Devices	0.19	2.08	1.51
GM General Motors	1.46	1.21	1.04
LEN Lennar	0.12	3.65	0.49
MSGE Madison Square Garden Entertainment	60.61	0.57	0.57
OXY Occidental Petroleum	0.90	1.01	0.79
PFE Pfizer	0.64	1.26	0.96
TRIL Trillium Therapeutics	N/A	19.82	19.82

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ADI Analog Devices	86.81%
GM General Motors	92.67%
LEN Lennar	81.10%
MSGE Madison Square Garden Entertainment	96.86%
OXY Occidental Petroleum	88.70%
PFE Pfizer	68.36%
TRIL Trillium Therapeutics	87.15%

Insider Ownership

Company	Insider Ownership
ADI Analog Devices	0.33%
GM General Motors	0.54%
LEN Lennar	10.00%
MSGE Madison Square Garden Entertainment	17.85%
OXY Occidental Petroleum	0.31%
PFE Pfizer	0.06%
TRIL Trillium Therapeutics	9.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ADI Analog Devices	24,000	496.25 million	494.61 million	Optionable
GM General Motors	162,000	961.43 million	956.24 million	Optionable
LEN Lennar	13,265	263.79 million	237.42 million	Optionable
MSGE Madison Square Garden Entertainment	6,700	40.59 million	33.35 million	Optionable
OXY Occidental Petroleum	13,323	984.13 million	981.08 million	Optionable
PFE Pfizer	81,000	5.69 billion	5.68 billion	Optionable
TRIL Trillium Therapeutics	33	105.00 million	95.44 million	Optionable

GM, LEN, OXY, PFE, ADI, MSGE, and TRIL Headlines

Recent News About These Companies

Pfizer Ends Mid-Stage Trial for CD47 Blood Cancer Drug, Citing Recruitment Problems

July 1, 2025 | biospace.comB

Ratio Therapeutics and TerraPower Isotopes Sign Supply Agreement for Actinium-225 For Targeted Radiotherapeutics

June 20, 2025 | finance.yahoo.com

Trillium Therapeutics Stock Price History

May 26, 2025 | investing.com

TTI Consumer Power Tools, Inc. is Seeking an IP Paralegal

September 26, 2024 | ipwatchdog.comI

Advances in Drug Discovery & Development 2024

September 8, 2024 | technologynetworks.comT

When You Look Back in 5 Years, You'll Wish You'd Bought This $2 Trillion Artificial Intelligence (AI) Stock

July 30, 2024 | finance.yahoo.com

Google Cloud unveils the Trillium TPU, its most powerful AI processor so far

May 14, 2024 | siliconangle.comS

Cachet Bicycle shakes off COVID

February 25, 2024 | baytoday.caB

Rejuvenate your look with a trip to Fourth Avenue Medical Aesthetics

January 30, 2024 | chch.comC

TTI apprehends motorists for illegal removal of clamps, hunt for four others underway

January 30, 2024 | bulawayo24.comB

BridgeBio raises $1.25bn, and other biotech financings

January 19, 2024 | pharmaphorum.comP

Ratio Therapeutics Raises $50M in Series B Financing

January 17, 2024 | precisionmedicineonline.comP

Leiomyosarcoma Drug Pipeline Report 2023 - ResearchAndMarkets.com

November 10, 2023 | businesswire.com

Mirati Therapeutics Stock (NASDAQ:MRTX), Analyst Ratings, Price Targets, Predictions

November 8, 2023 | benzinga.com

The Global T-Cell therapy Market size is expected to reach $9.2 billion by 2030, rising at a market growth of 17.5% CAGR during the forecast period

July 31, 2023 | uk.finance.yahoo.com

Ratio Therapeutics unveils new research and development facility

May 15, 2023 | biopharma-reporter.comB

WHO Red Flags Punjab-Made Cough Syrup In Fresh Alert: 'Can Cause Even Death'

April 25, 2023 | msn.com

Leukemia Therapeutics Global Market Report 2023

April 4, 2023 | uk.finance.yahoo.com

Ratio Therapeutics Announces Licensing Agreement for Investigational PET Imaging Agent with Merck

March 28, 2023 | finance.yahoo.com

Trillium House, an affordable housing project in Warrenton, close to completion

January 9, 2023 | dailyastorian.comD

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Intel's Turnaround Strategy Shifts From Planning to Attack Mode
By Jeffrey Neal Johnson | June 20, 2025
View Intel's Turnaround Strategy Shifts From Planning to Attack Mode
Applied Digital: Now the High-Stakes Race to Build Begins
By Jeffrey Neal Johnson | June 17, 2025
View Applied Digital: Now the High-Stakes Race to Build Begins
Do They Know Something? Insiders & Congress Buy UnitedHealth
By Brian O'Connell | July 9, 2025
View Do They Know Something? Insiders & Congress Buy UnitedHealth
3 Overbought Stocks Ripe for a Pullback
By Ryan Hasson | July 7, 2025
View 3 Overbought Stocks Ripe for a Pullback
3 Stocks Hitting All-Time Highs With More Room to Run
By Dan Schmidt | June 27, 2025
View 3 Stocks Hitting All-Time Highs With More Room to Run

GM, LEN, OXY, PFE, ADI, MSGE, and TRIL Company Descriptions

Analog Devices NASDAQ:ADI

$244.68 -0.45 (-0.18%)

Closing price 04:00 PM Eastern

Extended Trading

$244.73 +0.05 (+0.02%)

As of 06:53 PM Eastern

Analog Devices, Inc. designs, manufactures, tests, and markets integrated circuits (ICs), software, and subsystems products in the United States, rest of North and South America, Europe, Japan, China, and rest of Asia. The company provides data converter products, which translate real-world analog signals into digital data, as well as translates digital data into analog signals; power management and reference products for power conversion, driver monitoring, sequencing, and energy management applications in the automotive, communications, industrial, and consumer markets; and power ICs that include performance, integration, and software design simulation tools for accurate power supply designs. It also offers amplifiers to condition analog signals; and radio frequency and microwave ICs to support cellular infrastructure; and micro-electro-mechanical systems technology solutions, including accelerometers used to sense acceleration, gyroscopes for sense rotation, inertial measurement units to sense multiple degrees of freedom, and broadband switches for radio and instrument systems, as well as isolators. In addition, the company provides digital signal processing and system products for numeric calculations. It serves clients in the industrial, automotive, consumer, instrumentation, aerospace, defense and healthcare, and communications markets through a direct sales force, third-party distributors, and independent sales representatives, as well as online. Analog Devices, Inc. was incorporated in 1965 and is headquartered in Wilmington, Massachusetts.

General Motors NYSE:GM

$53.36 +0.21 (+0.40%)

Closing price 03:59 PM Eastern

Extended Trading

$53.39 +0.03 (+0.06%)

As of 07:06 PM Eastern

General Motors Company designs, builds, and sells trucks, crossovers, cars, and automobile parts; and provide software-enabled services and subscriptions worldwide. The company operates through GM North America, GM International, Cruise, and GM Financial segments. It markets its vehicles primarily under the Buick, Cadillac, Chevrolet, GMC, Baojun, and Wuling brand names. In addition, the company sells trucks, crossovers, cars, and automobile parts through retail dealers, and distributors and dealers, as well as to fleet customers, including daily rental car companies, commercial fleet customers, leasing companies, and governments. Further, it offers range of after-sale services through dealer network, such as maintenance, light repairs, collision repairs, vehicle accessories, and extended service warranties. Additionally, the company provides automotive financing; and software-enabled services and subscriptions. General Motors Company was founded in 1908 and is headquartered in Detroit, Michigan.

Lennar NYSE:LEN

$114.04 -2.40 (-2.06%)

Closing price 03:59 PM Eastern

Extended Trading

$113.74 -0.30 (-0.26%)

As of 06:59 PM Eastern

Lennar Corporation, together with its subsidiaries, operates as a homebuilder primarily under the Lennar brand in the United States. It operates through Homebuilding East, Homebuilding Central, Homebuilding Texas, Homebuilding West, Financial Services, Multifamily, and Lennar Other segments. The company's homebuilding operations include the construction and sale of single-family attached and detached homes, as well as the purchase, development, and sale of residential land; and development, construction, and management of multifamily rental properties. It also offers residential mortgage financing, title, insurance, and closing services for home buyers and others, as well as originates and sells securitization commercial mortgage loans. In addition, the company is involved in the fund investment activity. It primarily serves first-time, move-up, active adult, and luxury homebuyers. Lennar Corporation was founded in 1954 and is based in Miami, Florida.

Madison Square Garden Entertainment NYSE:MSGE

$39.50 +0.34 (+0.86%)

Closing price 03:58 PM Eastern

Extended Trading

$39.49 -0.01 (-0.02%)

As of 06:11 PM Eastern

Madison Square Garden Entertainment Corp. engages in the provision of entertainment services. Its portfolio of venues includes The Garden, Radio City Music Hall, the Beacon Theatre, The Theater at Madison Square, and The Chicago Theatre. The company was founded in 1879 and is headquartered in New York, NY.

Occidental Petroleum NYSE:OXY

$46.33 +0.48 (+1.05%)

Closing price 03:59 PM Eastern

Extended Trading

$46.18 -0.15 (-0.32%)

As of 07:11 PM Eastern

Occidental Petroleum Corporation, together with its subsidiaries, engages in the acquisition, exploration, and development of oil and gas properties in the United States, the Middle East, and North Africa. It operates through three segments: Oil and Gas, Chemical, and Midstream and Marketing. The company's Oil and Gas segment explores for, develops, and produces oil and condensate, natural gas liquids (NGLs), and natural gas. Its Chemical segment manufactures and markets basic chemicals, including chlorine, caustic soda, chlorinated organics, potassium chemicals, ethylene dichloride, chlorinated isocyanurates, sodium silicates, and calcium chloride; and vinyls comprising vinyl chloride monomer, polyvinyl chloride, and ethylene. The Midstream and Marketing segment gathers, processes, transports, stores, purchases, and markets oil, condensate, NGLs, natural gas, carbon dioxide, and power. This segment also invests in entities. Occidental Petroleum Corporation was founded in 1920 and is headquartered in Houston, Texas.

Pfizer NYSE:PFE

$25.65 -0.13 (-0.50%)

Closing price 03:59 PM Eastern

Extended Trading

$25.62 -0.02 (-0.10%)

As of 07:10 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Trillium Therapeutics NASDAQ:TRIL

Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest GM, LEN, OXY, PFE, ADI, MSGE, and TRIL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest GM, LEN, OXY, PFE, ADI, MSGE, and TRIL Earnings

Compare Dividends

Latest GM, LEN, OXY, PFE, ADI, MSGE, and TRIL Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

GM, LEN, OXY, PFE, ADI, MSGE, and TRIL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

GM, LEN, OXY, PFE, ADI, MSGE, and TRIL Company Descriptions

Analog Devices NASDAQ:ADI

General Motors NYSE:GM

Lennar NYSE:LEN

Madison Square Garden Entertainment NYSE:MSGE

Occidental Petroleum NYSE:OXY

Pfizer NYSE:PFE

Trillium Therapeutics NASDAQ:TRIL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools